2007
DOI: 10.1590/s1413-86702007000700015
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of chronic hepatitis C in treatment-naïve patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2012
2012
2013
2013

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
1
0
1
Order By: Relevance
“…Since the sample consisted of patients who used PEG-IFN, a higher percentage of patients with genotype 1 was expected. HCV genotype is an important parameter in the indication of treatment, given that genotype 1 presents lower rates of SVR compared with other genotypes, which is why patients with genotype 1 are treated for 48 weeks, while patients with other genotypes are treated for 24 weeks (Ferreira, 2007;Fried, Hadziyannis, 2004;Shepherd et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Since the sample consisted of patients who used PEG-IFN, a higher percentage of patients with genotype 1 was expected. HCV genotype is an important parameter in the indication of treatment, given that genotype 1 presents lower rates of SVR compared with other genotypes, which is why patients with genotype 1 are treated for 48 weeks, while patients with other genotypes are treated for 24 weeks (Ferreira, 2007;Fried, Hadziyannis, 2004;Shepherd et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Usuários de drogas inalatórias ou intravenosas ilícitas, contágio vertical, contágio sexual, receptores de órgãos transplantados, também são vias de transmissão (Strauss, 2001;Indolfi et al, 2013;Prati, 2006). (Gallo et al, 2010;Rocca et al, 2004;Feld et al, 2010 (Ferreira, 2007;Czepiel et al, 2008;Georgel et al, 2010). (Mangia et al, 2010;Tanaka et al, 2010;Cannon et al, 2008;Pol et al, 2013).…”
Section: Transmissãounclassified